title: Having "Skin in the Game" and Allowing Cross-Border Importation of Drugs to Lower High Prices of Cancer Drugs.
authors.affiliation: Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston.
authors.forename: Hagop
authors.initials: H
authors.lastname: Kantarjian
authors.affiliation: Epocrates Medical Information, AthenaHealth, San Francisco, California.
authors.forename: Michael S
authors.initials: MS
authors.lastname: Mathisen
authors.affiliation: Princess Margaret Cancer Centre, University of Toronto, Toronto, Ontario, Canada.
authors.forename: Jeffrey H
authors.initials: JH
authors.lastname: Lipton
mesh_terms: D000970:Antineoplastic Agents / Q000191:economics* / Q000600:supply & distribution*; D002170:Canada; D003132:Commerce; D016527:Drug Costs; D004345:Drug Industry / Q000191:economics*; D016568:Drugs, Generic / Q000191:economics / Q000600:supply & distribution; D006297:Health Services Accessibility / Q000191:economics*; D054625:Healthcare Disparities / Q000191:economics; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy* / Q000191:economics*; D010330:Patents as Topic; D014481:United States
chemical_list: D000970:Antineoplastic Agents; D016568:Drugs, Generic